We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.13B
AUM Growth
+$319M
Cap. Flow
+$340M
Cap. Flow %
30.15%
Top 10 Hldgs %
55.39%
Holding
5,820
New
1,131
Increased
1,662
Reduced
1,677
Closed
1,185

Sector Composition

Rank Sector Weight
1 Financials 2.49%
2 Industrials 2.24%
3 Healthcare 2.07%
4 Consumer Discretionary 2.05%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NHLD
3651
DELISTED
National Holdings Corporation
NHLD
$3K ﹤0.01%
851
+751
+751% +$2.75K
BAS
3652
DELISTED
Basis Energy Services, Inc.
BAS
$3K ﹤0.01%
1
-2
-67% -$9.72K
TSS
3653
DELISTED
Total System Services, Inc.
TSS
$3K ﹤0.01%
77
-2,523
-97% -$102K
ATTU
3654
DELISTED
Attunity Ltd
ATTU
$3K ﹤0.01%
+252
New +$3.08K
WMLP
3655
DELISTED
Westmoreland Resrc Partners, L.P
WMLP
$3K ﹤0.01%
350
+250
+250% +$2.77K
DIRT
3656
DELISTED
iPath Pure Beta Agriculture ETN
DIRT
$3K ﹤0.01%
+95
New +$3.25K
FAC
3657
DELISTED
First Acceptance Corp.
FAC
$3K ﹤0.01%
800
+624
+355% +$1.89K
WIBC
3658
DELISTED
WILSHIRE BANCORP INC
WIBC
$3K ﹤0.01%
206
-7,946
-97% -$88.1K
XUE
3659
DELISTED
XUEDA EDUCATION GROUP ADS REPTG 2 ORD SHS
XUE
$3K ﹤0.01%
758
+726
+2,269% +$2.51K
CZR
3660
DELISTED
Caesars Entertainment Corporation
CZR
$3K ﹤0.01%
500
-356
-42% -$3.22K
CFD
3661
DELISTED
Nuveen Diversified Commodity Fnd
CFD
$3K ﹤0.01%
253
-39
-13% -$475
AAON icon
3662
Aaon
AAON
$7.77B
$2K ﹤0.01%
150
-3,759
-96% -$59.6K
ADUS icon
3663
Addus HomeCare
ADUS
$2.23B
$2K ﹤0.01%
89
-1,660
-95% -$45.5K
AKAM icon
3664
Akamai
AKAM
$15.9B
$2K ﹤0.01%
25
-1,108
-98% -$82.2K
ALDX icon
3665
Aldeyra Therapeutics
ALDX
$93.5M
$2K ﹤0.01%
220
-1,024
-82% -$8.83K
APT icon
3666
Alpha Pro Tech
APT
$53.1M
$2K ﹤0.01%
711
-349
-33% -$813
ARTNA icon
3667
Artesian Resources
ARTNA
$358M
$2K ﹤0.01%
95
-528
-85% -$11.3K
ASEA icon
3668
Global X FTSE Southeast Asia ETF
ASEA
$102M
$2K ﹤0.01%
101
+61
+153% +$958
ATEC icon
3669
Alphatec Holdings
ATEC
$1.44B
$2K ﹤0.01%
133
+100
+303% +$1.67K
ATOS icon
3670
Atossa Therapeutics
ATOS
$23.5M
$2K ﹤0.01%
1
-3
-75% -$12K
BCLI
3671
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$2K ﹤0.01%
32
+24
+300% +$1.43K
BIZD icon
3672
VanEck BDC Income ETF
BIZD
$1.7B
$2K ﹤0.01%
+100
New +$1.83K
BKTI icon
3673
BK Technologies
BKTI
$291M
$2K ﹤0.01%
71
+60
+545% +$1.74K
BYFC icon
3674
Broadway Financial
BYFC
$103M
$2K ﹤0.01%
175
-71
-29% -$803
CAE icon
3675
CAE Inc. Common Shares
CAE
$8.74B
$2K ﹤0.01%
+137
New +$1.67K

Similar funds

Tower Research Capital (TRC)'s Q2 2015 Portfolio in Review

As of Q2 2015, Tower Research Capital (TRC) held 5,820 positions worth $1.13B, up 39% from $809M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC) deployed $340M of net new capital in Q2 2015, opening 1,131 new positions and adding to 1,662 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.

By sector, the portfolio is most concentrated in Financials at 2.5% of assets, down from 4.6% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $42.4M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2015 buy was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $337M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2015 reduction was Invesco QQQ Trust, cutting an estimated $42.4M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q2 2015, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.13B portfolio in Q2 2015.
  • Tower Research Capital (TRC) opened 1,131 new positions and closed 1,185 in Q2 2015.
  • Tower Research Capital (TRC)'s portfolio value rose 39% quarter-over-quarter to $1.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.